VEGFA and triple-negative breast carcinoma: –von Wahlde M-K, Hülsewig C, Ruckert C, Götte M, Kiesel L, Bernemann C. The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling. Gynecol Endocrinol. 2015 Feb;31(2):160–4.